SEC FORM 4
$42,133,000.00
Keenova Therapeutics plc (NONE)
Purchase of 463,000 shares at $91.00 per share.
Reporting Persons GOLDENTREE ASSET MANAGEMENT LP · GoldenTree Asset Management LLC · Tananbaum Steven A. · Transaction Code P
Traded Sep 24, 2026 · Disclosed Oct 6, 2026FILED +12 DAYS
Source: SEC Form 4 · 0001493152-26-045958 · filed 2026-10-06 · View filing →